TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Novartis May Sell U.S. Generic Pill Business Amid Industry Struggles
STOCKS

Novartis Reportedly Preps Sale Process for U.S. Generic Pill Business

Otonomy Shares Rebound After Wednesday's Drop- Biotech Movers
STOCKS

Impax Shares Jump on Merger Buzz

Mesoblast Soars on Stem-Cell Treatment Data
HEALTH

Impax Shares Jump After Chinese Firm Reveals 5% Stake

Mesoblast Soars on Stem-Cell Treatment Data
HEALTH

Teva, Mylan Seen to Stay on M&A Sidelines

Teva Pharmaceutical Will Bounce Big Soon for Traders: Chart
STOCKS

Teva's Post Earnings Selloff Triggers Oppenheimer, Fitch Downgrades

Generics Drop Across Board as DOJ Inquiry Expands
STOCKS

Teva Shares Are Getting Obliterated Again After a Vicious Investment Bank Downgrades

Teva Pharmaceutical Will Bounce Big Soon for Traders: Chart
STOCKS

Teva Shares Are Taking a Beating and Dragging Down the Entire Drug Sector

Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
HEALTH

Biotech Movers: Impax Shares Jump On FDA Approval for Generic Version of Concerta

Mesoblast Soars on Stem-Cell Treatment Data
HEALTH

Biotech Movers: Immuno-Oncology Pact With Celgene Sends BeiGene Shares Soaring

Mesoblast Soars on Stem-Cell Treatment Data
HEALTH

Biotech Movers: Adamis Shares Jump After FDA Approval For Epinephrine Pre-filled Syringe

Pfizer Announces Big Reorganization As It Continues Trying to Sell Consumer Biz
MERGERS AND ACQUISITIONS

Amneal, Impax, Other Struggling Generics Face M&A Dilemma

Depomed, Insys Shares Down After FDA Decision on Endo's Opana ER
HEALTH

Depomed, Insys Shares Down After FDA Decision on Endo's Opana ER

Generics Drop Across Board as DOJ Inquiry Expands
STOCKS

Generics Drop Across Board as DOJ Inquiry Expands

Perrigo Unveils Divestitures, Says It's Open to Making Bolt-On Acquisitions
STOCKS

Perrigo Stock Sliding on DOJ Search

Why the AHCA Has Already Failed
STOCKS

Impax Gains 38% On CEO Appointment, Talk of Sale

Acorda Therapeutics Sinks on Invalidated Patents
STOCKS

Skincare Makers Lead Biotech Movers

Sanofi Sues Mylan Over EpiPen Practices
STOCKS

Politicians Question EpiPen Competitor Auvi-Q's High Pricetag

Biotech Movers: Lion Biotechnologies, XBiotech, Halozyme
HEALTH

Biotech Premarket Movers: Impax, Clearside Biomedical, Mylan

VA to Test Partnership With CVS to Reduce Veteran Wait Times
STOCKS

CVS Remains Unsure About the Future of Obamacare

Mylan's Shares Rise Despite FTC Investigation
STOCKS

Mylan's shares rise despite FTC investigation

Express Scripts, Cigna Opt Out of Paying for EpiPen Competitor Auvi-Q
STOCKS

Neither Express Scripts nor Cigna will pay for Auvi-Q

Sanofi Sues Mylan Over EpiPen Practices
STOCKS

EpiPen competitor Auvi-Q will hit the market in February

Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
STOCKS

Biotech premarket movers: SGMO, IPXL, PTLA

Mylan's Shares Rise Despite FTC Investigation
STOCKS

Mylan crushed by Trump, Cigna and CVS -- all in two days

CVS Takes Up Beauty Image Transparency Mantle
STOCKS

CVS is the latest to rock Mylan's EpiPen empire